TNFSF13B and inflammatory bowel disease: Finally, respecting the pathogenetic role of BAFF in IBD and driven by the clinical success of BAFF inhibitors in multiple autoimmune diseases, it is reasonable that targeting BAFF could be a novel and unexplored strategy in IBD treatment.